Xtant Medical Holdings XTNT Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 62.3%+4.2pp | 62.9%+4.8pp | 62%+1.1pp | 60.2%-1.5pp | 58.2%-3.3pp | |
| Net margin | 1.5%+11.3pp | 3.7%+17.7pp | 1.3%— | -3.6%— | -9.8%— | |
| Returns | ||||||
| Return on equity | 3.9%+30.1pp | 10.6%+45.5pp | 3.6%— | -9.8%— | -26.2%— | |
| Return on invested capital | 5.8%+18.1pp | 13.5%+32.9pp | 8%+30.1pp | 0%+25.3pp | -12.3%+10.2pp | |
| Efficiency | ||||||
| Asset turnover | 1.4×+0.1× | 1.4×+0.2× | 1.3×+0.1× | 1.3×-0.1× | 1.3×0.0× | |
| Liquidity | ||||||
| Current ratio | 3.3×+1.0× | 2.7×+0.3× | 2.2×+0.1× | 2.5×0.0× | 2.3×0.0× | |
| Leverage | ||||||
| Debt-to-equity | 0.3×-0.2× | 0.4×-0.2× | 0.4×-0.1× | 0.5×0.0× | 0.5×+0.1× | |
| Net debt / EBITDA | 0.3×— | 0×— | 1×— | 4×— | —— | |
| Per Share | ||||||
| Book value per share | $0.35+13.4% | $0.34+5.7% | $0.34-1.0% | $0.33-5.5% | $0.31-16.4% | |
| Valuation | ||||||
| Market capitalization | $59.05M-32.5% | $109.76M+78.2% | $90.85M-3.1% | $88.61M+8.0% | $65.36M-57.1% | |
| Price / earnings | 32.3×— | 22.1×— | 51.9×— | —— | —— | |
| Price / sales | 0.5×-0.2× | 0.8×+0.3× | 0.7×-0.1× | 0.7×0.0× | 0.5×-1.0× | |
| Price / book | 1.2×-0.6× | 2.2×+0.7× | 1.8×-0.2× | 1.8×0.0× | 1.5×-1.7× | |
| EV / EBITDA | 5.4×-17.7× | 7×— | 9.3×— | 23.7×— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Xtant Medical Holdings's profit margins?
- Xtant Medical Holdings (XTNT) runs a 62.3% gross margin and a 4.8% operating margin, with a 1.5% net margin.
- Where do Xtant Medical Holdings's ratios come from?
- Every ratio is computed from Xtant Medical Holdings's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
